Sign in
Taking people in United StatesNo phase

Evaluation of Diagnostic Accuracy and Clinical Performance of the UllCORE Bloodstream Infection (BSI) Test

Key facts

Who runs it
Deepull Diagnostics S.L.
Where
Baltimore, Boston, Cleveland, Danville, Nashville, Novi, Orange, St Louis, Tampa, and Temple, United StatesSee the 10 sitesAlso in 4 other countries, 10 sites
Trial code
Status
Recruiting
People taking part
1,500 people, planned
Started
21 Sept 2026
Expected to end
Oct 2027
Type of study
Observational
Treatments tested
  • UllCORE BSI Test
Record updated
8 October 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Any age (where the remaining criteria can be safely fulfilled)
  • Ability to provide consent/assent in accordance with Institutional Review Board (IRB)/Ethics Committee (EC) determinations
  • The patient is presenting with signs and symptoms of suspected bloodstream infection (BSI) or fulfils the criteria for the hospital sepsis protocol; Planned blood culture collection and laboratory analysis as per standard of care (SOC)
  • Patient is able and an appropriate candidate to be able to collect 2 K2 ethylenediaminetetraacetic acid (EDTA) tubes of whole blood

Who cannot take part

  • Patient was previously enrolled in the study
  • Unable to collect UllCORE BSI Test samples from the same venipuncture as blood culture (BC) samples

Where in United States

Also in 4 other countries, 10 sites

  • The Johns Hopkins HospitalBaltimore, United StatesContact: Roger CantonNot yet recruiting
  • Beth Israel Deaconess Medical CenterBoston, United StatesContact: Roger CantonNot yet recruiting
  • University Hospitals Cleveland Medical Center*Cleveland, United StatesContact: Roger CantonTaking people
  • Geisinger HealthDanville, United StatesContact: Roger CantonNot yet recruiting
  • Vanderbilt HealthNashville, United StatesContact: Roger CantonNot yet recruiting
  • Henry Ford HealthNovi, United StatesContact: Roger CantonNot yet recruiting
  • University of California at Irvine Medical CenterOrange, United StatesContact: Roger CantonNot yet recruiting
  • Washington University School of MedicineSt Louis, United StatesContact: Roger CantonNot yet recruiting
  • Tampa General HospitalTampa, United StatesContact: Roger CantonNot yet recruiting
  • Baylor Scott & White Health Medical Center-TempleTemple, United StatesContact: Roger CantonNot yet recruiting

About the trial

What the trial wants to find out

This study is designed to evaluate the clinical performance of the UllCORE Bloodstream Infection (BSI) Test, an investigational molecular diagnostic test intended to detect microorganisms and selected antimicrobial resistance markers directly from whole blood in patients with suspected bloodstream infection or sepsis.

Read full original descriptionShow less

Participants enrolled in the study will have blood collected at the same time as blood samples obtained for standard-of-care blood culture testing. Study blood samples will be tested using the UllCORE BSI Test either as fresh samples or after frozen storage, according to the study protocol.

The results of the UllCORE BSI Test will be compared with standard-of-care microbiology results and, when applicable, additional testing methods to assess the diagnostic performance of the investigational test.

The UllCORE BSI Test results will not be used to guide patient care and will not be provided to treating healthcare professionals for clinical decision-making. Participation in the study will therefore not change the standard medical care received by participants.

The group in the trial

  • Participants with Suspected Bloodstream Infection or Sepsis

    Participants with suspected bloodstream infection or sepsis whose prospectively collected whole-blood specimens are either tested fresh using the investigational UllCORE Bloodstream Infection (BSI) Test or stored frozen before subsequent testing. UllCORE BSI Test results will be compared with standard-of-care microbiology results and will not be used for clinical decision-making.

    Treatment: UllCORE BSI Test

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
8 October 2026